Trials / Sponsors / Applied Biology, Inc.
Applied Biology, Inc.
Industry · 25 registered clinical trials — 8 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | Clinical Study of DA-001 as a Treatment for Hair Shedding Reduction and Hair Re-Growth Telogen Effluvium, Female Pattern Hair Loss, Female Pattern Hair Loss, Androgenic Alopecia | Phase 2 / Phase 3 | 2026-05-01 |
| Not Yet Recruiting | Clinical Study of DA-020 for the Treatment of Chemotherapy Induced Alopecia Chemotherapy Induced Alopecia, Chemotherapy Side Effects | Phase 1 / Phase 2 | 2026-04-16 |
| Not Yet Recruiting | Pharmacokinetic Study of DA-020 Chemotherapy Induced Alopecia, Chemotherapy Side Effects | EARLY_Phase 1 | 2026-04-16 |
| Not Yet Recruiting | Clinical Study of DA-007 for the Treatment of Chemotherapy Induced Alopecia Chemotherapy Induced Alopecia, Chemotherapy Side Effects | Phase 3 | 2025-10-10 |
| Not Yet Recruiting | Clinical Study of mTOR Inhibitor as a Treatment for Grey Hair (Canities) Canities, Grey Hair | Phase 1 / Phase 2 | 2025-10-01 |
| Recruiting | Pharmacokinetic Study of Topical Phenylephrine Chemotherapy Induced Alopecia, Chemotherapy Side Effects | EARLY_Phase 1 | 2025-06-30 |
| Not Yet Recruiting | Clinical Study of CS-001 As a Treatment for Canities (Grey Hair) Canities, Grey Hair | Phase 3 | 2025-06-15 |
| Not Yet Recruiting | Clinical Study of DA-002 and DA-005 As a Treatment for Hair Loss Androgenetic Alopecia, Female Pattern Baldness, Male Pattern Baldness | Phase 3 | 2025-01-15 |
| Withdrawn | Clinical Study of Probiotic Treatment for Androgenetic Alopecia Androgenetic Alopecia, Female Pattern Baldness | Phase 3 | 2024-09-15 |
| Withdrawn | Comparison of JW-100 and EUCRISA for the Treatment of Atopic Dermatitis Atopic Dermatitis | Phase 3 | 2022-11-24 |
| Completed | Study to Investigate the Effectiveness of a Topical Cosmetic Formulation DA-OTC-002 Hair Diseases, Alopecia, Hair Loss | N/A | 2022-11-18 |
| Unknown | Treatment for Post Acute COVID-19 Syndrome Tinnitus, Subjective | N/A | 2022-10-01 |
| Unknown | HC-1119 Adjuvant Treatment for Hospitalized COVID-19 Patients COVID-19 Respiratory Infection | Phase 3 | 2022-04-15 |
| Withdrawn | Proxalutamide Treatment for COVID-19 Patients in Intensive Care Unit Covid19, SARS (Severe Acute Respiratory Syndrome) | Phase 3 | 2021-02-08 |
| Completed | Proxalutamide Treatment for Hospitalized COVID-19 Patients Covid19, SARS (Severe Acute Respiratory Syndrome) | Phase 3 | 2021-02-01 |
| Withdrawn | Proxalutamide Treatment for COVID-19 Female Outpatients Covid19, SARS-CoV Infection | Phase 3 | 2020-11-01 |
| Completed | Anti-Androgen Treatment for COVID-19 COVID-19, SARS-CoV2, Androgenetic Alopecia | N/A | 2020-10-21 |
| Withdrawn | HairDx Analytical Validation Study Hair Loss, Hair Loss/Baldness, Female Pattern Baldness | — | 2020-06-15 |
| Withdrawn | In-vitro Diagnostic Test to Predict COVID-19 Mortality and Disease Severity SARS-CoV 2, COVID, COVID-19 | — | 2020-05-01 |
| Completed | Study to Investigate the Effect of AB-101 in Breast Cancer Survivors Sexual Dysfunction, Sexual Arousal Disorder, Sexual Dysfunction, Physiological | EARLY_Phase 1 | 2018-07-09 |
| Completed | Minoxidil Response Testing in Males With Androgenetic Alopecia Androgenetic Alopecia | — | 2014-07-01 |
| Completed | Minoxidil Response Testing in Females With Female Pattern Hair Loss Alopecia, Female Pattern Hair Loss | — | 2014-07-01 |
| Completed | Photocil (Topical) for the Treatment of Vitiligo Vitiligo | N/A | 2013-08-01 |
| Completed | Photocil (Topical) for the Treatment of Atopic Dermatitis Atopic Dermatitis | N/A | 2013-08-01 |
| Completed | Photocil (Topical) for the Treatment of Psoriasis Vulgaris Psoriasis | N/A | 2013-08-01 |